Gladstone Science Talks
Wednesday, November 18, 2020

Lennart Mucke, MD

Senior Investigator and Director, Gladstone Institute of Neurological Disease

Lennart Mucke’s lab focuses on how major neurological and psychiatric conditions, such as Alzheimer’s disease and autism spectrum disorders, cause cognitive deficits, behavioral abnormalities, and other disabling symptoms. The group’s ultimate goal is to advance the understanding of devastating brain disorders to a point where transformative treatments can be developed for their prevention, control, and reversal. Mucke’s discoveries regarding the role of tau in the regulation of neuronal activity paved the path toward the development of tau-lowering therapeutics. In addition, Mucke’s investigations of patients with Alzheimer’s disease and related models shed new light on the intriguing overlap between Alzheimer’s disease and epilepsy.

Details

Date
November 18, 2020
Time
11:00am-12:00pm PST
Location
Online
Audience
Scientific
Contact(s)





Gladstone Science Talks allow investigators to share the latest research from their laboratories. These talks are open to the broader Gladstone community.

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.